LLY News and Press, Eli Lilly and Company From 04/28/24

2024-04-28 01:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-27 11:10:00 ET Nvidia has been an amazing stock to own over the past few years, generating incredible returns for investors. But the risk is that expectations may be too high for the stock, especially with respect to artificial intelligence (AI). And that means the stock could b...

2024-04-27 09:15:00 ET One of the hottest areas in the pharmaceutical space right now is weight loss. Glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound have become staples for treating diabetes and obesity. Eli Lilly (NYSE: LLY) ...

2024-04-27 07:15:00 ET Buy, hold, rake in solid income. That sounds like a pretty good investing strategy. You only have to find the right stocks worthy of holding for the long term and that pay attractive dividends. Three Motley Fool contributors think they can help out on that front. ...

2024-04-26 15:00:06 ET More on the markets SPY: The 'Value' From Equities Is Historically Low SPY: The Setup Looks Extremely Bearish Be Greedy When Others Are Fearful, Even If They Are Fearful For A Good Reason BofA watched clients retract $2B last week as th...

2024-04-26 14:04:32 ET This week was one of the heaviest in terms of companies that reported their first quarter earnings. Here is a recap of a few popular names that have reported their results.... Read the full article on Seeking Alpha For further details see: More than ha...

2024-04-26 12:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...

2024-04-26 12:00:34 ET Summary Novo Nordisk's weight loss drug, Wegovy, has received FDA approval for reducing the risk of major cardiovascular adverse events. Wegovy demonstrated a 20% reduction in the risk of major cardiovascular adverse events and a 19% reduction in the risk of...

2024-04-26 11:33:56 ET Summary Shares of AstraZeneca reached new all-time highs this week despite difficult market conditions in the last two months. The revenue and EPS beats were driven by the strong performance of all key growth products. Recent pipeline wins from Imfinzi, ...

2024-04-26 09:00:00 ET Summary Eaton Vance Enhanced Equity Income Fund is a closed-end fund that mainly invests in the equities of U.S. listed companies. The EOI CEF has a pretty strong long-term record of performance, even though it tends to underperform the S&P 500 slightly....